Virological response and safety outcomes in therapy-naïve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study - Gish,R.G.; Arora,S.; Reddy,K.R. (J Hepatol, 2007)